Save the Date
BIO InvestorForum 2007

October 10 - 12, 2007
Palace Hotel
San Francisco



About the BIO ToolBar

Presenting Companies

Listed below are the companies that were selected to present at the 2006 BIO InvestorForum.

To view presenting companies by category, please click here.

Aastrom Biosciences, Inc.  (NASDAQ : ASTM)
ACADIA Pharmaceuticals Inc.  (NASDAQ : ACAD)
Acceleron Pharma
Acorda Therapeutics Inc.  (NASDAQ : ACOR)
Acusphere, Inc.  (NASDAQ : ACUS)
Adherex Technologies Inc.  (AMEX : ADH)
Advanced Cell Technology  (OTCBB : ACTC)
Advanced Life Sciences  (NASDAQ : ADLS)
ADVENTRX Pharmaceuticals, Inc.  (AMEX : ANX)
Aegera Therapeutics Inc.
Ęterna Zentaris Inc.  (TSX : AEZ)
Agensys, Inc.
Alexza Pharmaceuticals, Inc.  (NASDAQ : ALXA)
Allos Therapeutics, Inc.  (NASDAQ : ALTH)
Alnylam Pharmaceuticals, Inc.  (NASDAQ : ALNY)
Alteon Inc.  (AMEX : ALT)
Ambit
Ambrilia Biopharma  (TSX : AMB)
Anadys Pharmaceuticals, Inc.  (NASDAQ : ANDS)
Anesiva, Inc.  (NASD : ANSV)
Antisoma plc  (LSE : ASM)
Archemix Corp.
Arena Pharmaceuticals, Inc.  (Nasdaq : ARNA)
ArQule, Inc.  (Nasdaq : ARQL)
Astex Therapeutics Limited
Avalon Pharmaceuticals  (NASDAQ : AVRX)
AVANT Immunotherapeutics, Inc.  (NASDAQ : AVAN)
Avera Pharmaceuticals, Inc.
Avicena Group  (OTCBB : AVGO)
Avidia, Inc.
Avigen, Inc.  (NASDAQ : AVGN)
Bayhill Therapeutics
BioCryst Pharmaceuticals, Inc.  (NASDAQ : BCRX)
Biolex Inc.
Bionovo  (OTC BB : BNVI.OB)
BioRexis Pharmaceutical Corporation
BioSante Pharmaceuticals  (Amex : BPA)
BioSeek, Inc.
Catalyst Biosciences, Inc.
Cell Genesys, Inc.  (NASDAQ : CEGE)
Cell Therapeutics, Inc.  (Nasdaq : CTIC)
Cellerant Therapeutics, Inc.
Ceregene, Inc.
Cerexa, Inc.
CGK Co., Ltd.
Chelsea Therapeutics, Inc.  (Nasdaq : CHTP)
ChemGenex Pharmaceuticals  (NASDAQ : CXSP)
Codexis, Inc.
Coley Pharmaceutical Group, Inc.  (NASDAQ : COLY)
CombinatoRx, Incorporated  (NASDAQ : CRXX)
Compugen  (NASDAQ : CGEN)
CrystalGenomics,Inc.  (KOSDAQ : Crystal)
Cumbre Pharmaceuticals Inc
Curis  (NASDAQ : CRIS)
Cyclacel Pharmaceuticals, Inc.  (NASDAQ : CYCC)
Cytokinetics, Inc.  (NASDAQ : CYTK)
CytRx Corporation  (NASDAQ : CYTR)
diaDexus, Inc.
Diversa Corporation  (NASDAQ : DVSA)
Domantis Ltd.
Durect Corporation  (NASDAQ : DRRX)
Dyax Corp.  (NASDAQ : DYAX)
Dynogen Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc.
Elusys Therapeutics, Inc.
Emisphere Technologies, Inc.  (Nasdaq : EMIS)
ENKAM Pharmaceuticals A/S
EntreMed, Inc.  (NASDAQ : ENMD)
EpiCept Corporation  (NASDAQ : EPCT)
Exelixis, Inc.  (NASDAQ : EXEL)
Favrille, Inc.  (Nasdaq : FVRL)
Gemin X Biotechnologies Inc.
Genaera Corporation  (NASDAQ : GENR)
GenVec, Inc.  (NASDAQ : GNVC)
Geron Corporation  (NASDAQ : GERN)
GlobeImmune Inc.
GPC Biotech AG  (Frankfurt : GPC)
Halozyme Therapeutics, Inc.  (Amex : HTI)
Hana Biosciences  (NASDAQ : HNAB)
Hollis-Eden Pharmaceuticals, Inc.  (NASDAQ : HEPH)
Icagen, Inc.  (Nasdaq : ICGN)
IDM Pharma Inc  (Nasdaq : IDMI)
ImmunoGen, Inc.  (NASDAQ : IMGN)
Infinity Pharmaceuticals, Inc.  (NASDAQ : INFI)
Inimex Pharmaceuticals Inc.
Innovive Pharmaceuticals Corporation  (OTC : IVPH.OB)
Inotek Pharmaceuticals Corporation
Inovio Biomedical Corporation  (AMEX : INO)
Insmed Incorporated  (NASDAQ : INSM)
Inspire Pharmaceuticals, Inc.  (NASDAQ : ISPH)
Intarcia Therapeutics, Inc.
Iomai Corporation  (NASDAQ : IOMI)
Javelin Pharmaceuticals, Inc.  (AMEX : JAV)
JJ Pharma, Inc.
Juvaris BioTherapeutics, Inc.
KAI Pharmaceuticals, Inc.
Kereos, Inc.
KineMed, Inc.
Koronis Pharmaceuticals
Labcyte Inc.
LigoCyte Pharmaceuticals
Linguagen Corp.
Locus Pharmaceuticals, Inc.
Lux Biosciences, Inc.
Manhattan Pharmaceuticals Inc.  (AMEX : MHA)
Marinus Pharmaceuticals, Inc.
MaxCyte, Inc.
MedExGen
Medicure Inc  (AMEX : MCU)
MediGene AG  (XETRA : MDG)
Medivation, Inc.  (Amex : MDV)
Merrimack Pharmaceuticals
Metabasis Therapeutics, Inc.  (NASDAQ : MBRX)
MethylGene Inc.  (TSX : MYG)
MIGENIX Inc.  (Toronto Stock Exchange : MGI)
Momenta Pharmaceuticals, Inc.  (NASDAQ : MNTA)
Monogram Biosciences  (NASDAQ : MGRM)
MorphoSys AG  (FSE (Germany) : MOR.DE)
MultiCell Technologies
Nabi Biopharmaceuticals  (Nasdaq : nabi)
Neotropix
neuralstem, inc.
Neurobiological Technologies, Inc.  (NASDAQ : NTII)
NeuroGeneration
Neuromed Pharmaceuticals Inc
NexMed, Inc.  (Nasdaq : NEXM)
Northfield Laboratories Inc.  (NASDAQ : NFLD)
Novadel Pharma Inc.  (AMEX : NVD)
Novocell, Inc.
Nucleonics, Inc.
Nventa Biophamaceuticals Corporation  (TSX : NVN)
Oncolytics Biotech Inc.  (TSX : ONC)
Onyx Pharmaceuticals, Inc.  (NASDAQ : ONXX)
Orexigen Therapeutics, Inc.
Orion Genomics
Osiris Therapeutics, Inc.  (NASDAQ : OSIR)
Osteologix, Inc.  (bulletin board : olgx.ob)
Othera Pharmaceuticals, Inc.
Palatin Technologies, Inc.  (AMEX : PTN)
Panacos Pharmaceuticals, Inc.  (NASDAQ : PANC)
Paratek Pharmaceuticals
Penwest Pharmaceuticals Co.  (NASDAQ : PPCO)
Peregrine Pharmaceuticals Inc.  (Nasdaq : PPHM)
Phenomix Corporation
Poniard Pharmaceuticals  (NASDAQ : PARD)
Portola Pharmaceuticals, Inc.
Pro-Pharmaceuticals, Inc.  (Amex : PRW)
Protein Sciences Corp.
Q Therapeutics
Raven biotechnologies, inc.
Reliant Pharmaceuticals, Inc.
Repligen Corporation  (NASDAQ : RGEN)
RHEI Pharmaceuticals
Rib-X Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.  (NASDAQ : RIGL)
Sangamo BioSciences, Inc.  (Nasdaq : SGMO)
SciClone Pharmaceuticals, Inc.  (NASDAQ : SCLN)
Seattle Genetics, Inc.  (Nasdaq : SGEN)
Serenex, Inc.
SGX Pharmaceuticals, Inc.  (NASDAQ : SGXP)
Sirna Therapeutics, Inc.  (NASDAQ : RNAI)
Sirtris Pharmaceuticals
Spectrum Pharmaceuticals, Inc.  (Nasdaq : SPPI)
SuperGen, Inc.  (NASDAQ : SUPG)
Surface Logix, Inc.
SyntheMed, Inc.  (OTCBB : SYMD)
TargeGen Inc.
Target Discovery, Inc.
Targeted Genetics Corporation  (NASDAQ : TGEN)
Titan Pharmaceuticals, Inc.  (AMEX : TTP)
TOPIGEN Pharmaceuticals Inc.  (N/A : N/A)
Tranzyme Pharma
Vasogen Inc.  (Nasdaq GM : VSGN)
Ventaira Pharmaceuticals, Inc.
VIA Pharmaceuticals, Inc.
Vical Incorporated  (NASDAQ : VICL)
VioQuest Pharmaceuticals, Inc  (OTC BB : VQPH)
Viragen, Inc.  (Amex : VRA)
Vitae Pharmaceuticals, Inc.
VIVUS Inc.  (NASDAQ : VVUS)
Xanthus Pharmaceuticals, Inc.
XDx Inc.
Xencor, Inc.
ZIOPHARM Oncology, Inc  (NASDAQ : ZIOP)